Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients
To compare the efficacy of the combination of lenalidomide with low-dose melphalan versus high-dose melphalan in newly diagnosed, symptomatic MM patients.
Multiple Myeloma|Newly Diagnosed Patients
DRUG: Melphalan|DRUG: Lenalidomide|DRUG: Prednisone|DRUG: Melphalan
Progression free survival, 5 years
Over all survival, 5 years
To compare the efficacy of the combination of lenalidomide with low-dose melphalan versus high-dose melphalan in newly diagnosed, symptomatic MM patients.